Amerisourcebergen reports q4 earnings per share $0.63

Amerisourcebergen reports fiscal 2019 fourth quarter and year end results.q4 adjusted earnings per share $1.61.q4 gaap earnings per share $0.63.q4 earnings per share estimate $1.58 -- refinitiv ibes data.revenues of $45.6 billion for q4, a 5.4 percent increase.recorded an after-tax charge of $50.9 million in quarter related to opioid litigation with two ohio counties.amerisourcebergen - engaged in discussions that include 4 ag's, regarding terms of potential framework for a global resolution of opioid litigation.amerisourcebergen - has not recognized liability related to potential framework for resolution of multi-district opioid litigation as of sept. 30.records a liability when it is probable that a loss has been incurred and amount is reasonably estimable.2020 adjusted. guidance reflects growth in pharmaceutical distribution services.2020 adjusted. guidance reflects growth in businesses focused on global commercialization services & animal health.sees fy adjusted. revenue growth in mid- to high-single digit percent range.sees fy 2020 adjusted earnings per share $7.30 to $7.60.sees fy capital expenditures in $400 million range.sees fy adjusted free cash flow to be about $1.5 billion.fy2020 earnings per share view $7.58, revenue view $188.00 billion -- refinitiv ibes data.q4 revenue view $45.20 billion -- refinitiv ibes data.
COR Ratings Summary
COR Quant Ranking